Akademska digitalna zbirka SLovenije - logo

Search results

Basic search    Expert search   

Currently you are NOT authorised to access e-resources SI consortium. For full access, REGISTER.

1 2 3 4 5
hits: 75
1.
  • Early Disease and Low Basel... Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real‐Life Setting
    Gatto, Mariele; Saccon, Francesca; Zen, Margherita ... Arthritis & rheumatology, August 2020, 2020-08-00, 20200801, Volume: 72, Issue: 8
    Journal Article
    Peer reviewed
    Open access

    Objective To investigate predictors of response, remission, low disease activity, damage, and drug discontinuation in patients with systemic lupus erythematosus (SLE) who were treated with belimumab. ...
Full text
Available for: BFBNIB, FZAB, GIS, IJS, KILJ, NLZOH, NUK, OILJ, SAZU, SBCE, SBMB, UL, UM, UPUK
2.
  • The role of chest CT in dec... The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19
    Orlandi, Martina; Landini, Nicholas; Sambataro, Gianluca ... Rheumatology (Oxford, England), 04/2022, Volume: 61, Issue: 4
    Journal Article
    Peer reviewed
    Open access

    Abstract Objective The aim of this study was to identify the main CT features that may help in distinguishing a progression of interstitial lung disease (ILD) secondary to SSc from COVID-19 ...
Full text
Available for: NUK, UL, UM, UPUK

PDF
3.
  • Inflammatory, Serological a... Inflammatory, Serological and Vascular Determinants of Cardiovascular Disease in Systemic Lupus Erythematosus Patients
    Mercurio, Valentina; Lobasso, Antonio; Barbieri, Letizia ... International journal of molecular sciences, 04/2019, Volume: 20, Issue: 9
    Journal Article
    Peer reviewed
    Open access

    Systemic lupus erythematosus (SLE) is associated with increased risk of cardiovascular disease (CVD). Among many mechanisms, accelerated atherosclerosis, endothelial dysfunction, and ...
Full text
Available for: IZUM, KILJ, NUK, PILJ, PNG, SAZU, UL, UM, UPUK

PDF
4.
  • Durable renal response and ... Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort
    Gatto, Mariele; Saccon, Francesca; Andreoli, Laura ... Journal of autoimmunity, November 2021, 2021-11-00, 20211101, Volume: 124
    Journal Article
    Peer reviewed

    Belimumab was recently approved for treatment of lupus glomerulonephritis (LN). To evaluate renal response and its predictors in LN patients receiving belimumab in real-life. We considered all ...
Full text
Available for: GEOZS, IJS, IMTLJ, KILJ, KISLJ, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UILJ, UL, UM, UPCLJ, UPUK, ZAGLJ, ZRSKP

PDF
5.
  • Kidney involvement in syste... Kidney involvement in systemic sclerosis: From pathogenesis to treatment
    Bruni, Cosimo; Cuomo, Giovanna; Rossi, Francesca W. ... Journal of Scleroderma and Related Disorders, 02/2018, Volume: 3, Issue: 1
    Book Review, Journal Article
    Peer reviewed
    Open access

    Among all possible systemic sclerosis internal organ complications, kidney involvement is frequently neglected or underestimated, except for the life-threatening scleroderma renal crisis. ...
Full text
Available for: NUK, OILJ, SAZU, UKNU, UL, UM, UPUK
6.
  • Persistence of Mast Cell-Po... Persistence of Mast Cell-Positive Synovitis in Early Rheumatoid Arthritis Following Treatment With Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs
    Rivellese, Felice; Rossi, Francesca W; Giorli, Giovanni ... Frontiers in pharmacology, 07/2020, Volume: 11
    Journal Article
    Peer reviewed
    Open access

    Mast cells (MCs) are immune cells infiltrating the synovial membrane and implicated in the pathogenesis of Rheumatoid Arthritis (RA). Their infiltration in the synovia of early RA patients has been ...
Full text
Available for: NUK, UL, UM, UPUK

PDF
7.
  • Urokinase type plasminogen ... Urokinase type plasminogen activator receptor (uPAR) as a new therapeutic target in cancer
    Montuori, Nunzia; Pesapane, Ada; Rossi, Francesca W ... Translational medicine @ UniSa, 11/2016, Volume: 15
    Journal Article
    Peer reviewed
    Open access

    The urokinase (uPA)-type plasminogen activator receptor (uPAR) is a GPI-anchored receptor that focuses urokinase (uPA) proteolytic activity on the cell surface. uPAR also regulates cell adhesion, ...
Full text
Available for: NUK, UL, UM, UPUK
8.
  • Helicobacter pylori Hp(2-20... Helicobacter pylori Hp(2-20) Promotes Migration and Proliferation of Gastric Epithelial Cells by Interacting with Formyl Peptide Receptors In Vitro and Accelerates Gastric Mucosal Healing In Vivo
    de Paulis, Amato; Prevete, Nella; Rossi, Francesca W ... The Journal of immunology (1950), 09/2009, Volume: 183, Issue: 6
    Journal Article
    Peer reviewed
    Open access

    Helicobacter pylori-derived peptide RpL1 aa 2-20 (Hp(2-20)) in addition to its antimicrobial action exerts several immunomodulatory effects in eukaryotic cells by interacting with formyl peptide ...
Full text
Available for: NUK, UL, UM, UPUK

PDF
9.
  • PED/PEA‐15 interacts with t... PED/PEA‐15 interacts with the 67 kD laminin receptor and regulates cell adhesion, migration, proliferation and apoptosis
    Formisano, Pietro; Ragno, Pia; Pesapane, Ada ... Journal of Cellular and Molecular Medicine, July 2012, Volume: 16, Issue: 7
    Journal Article
    Peer reviewed
    Open access

    Phosphoprotein enriched in diabetes/phosphoprotein enriched in astrocytes‐15 kD (PED/PEA‐15) is an anti‐apoptotic protein whose expression is increased in several human cancers. In addition to ...
Full text
Available for: FZAB, GIS, IJS, KILJ, NLZOH, NUK, OILJ, SAZU, SBCE, SBMB, UL, UM, UPUK

PDF
10.
  • Resistance to cabergoline a... Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: Prevalence, clinical definition, and therapeutic strategy
    DI SARNO, Antonella; LANDI, Maria Luisa; CAPPABIANCA, Paolo ... The journal of clinical endocrinology and metabolism, 11/2001, Volume: 86, Issue: 11
    Journal Article
    Peer reviewed
    Open access

    To evaluate the prevalence of resistance to cabergoline treatment, we studied 120 consecutive de novo patients (56 macroadenoma, 60 microadenoma, 4 nontumoral hyperprolactinemia) treated with ...
Full text
Available for: NUK, UL, UM, UPUK

PDF
1 2 3 4 5
hits: 75

Load filters